Articles with "chemotherapy plus" as a keyword



Photo from wikipedia

Comparison of Chemotherapy vs Chemotherapy Plus Total Hysterectomy for Women With Uterine Cancer With Distant Organ Metastasis

Sign Up to like & get
recommendations!
Published in 2021 at "JAMA Network Open"

DOI: 10.1001/jamanetworkopen.2021.18603

Abstract: This cohort study evaluates the overall survival for patients with uterine cancer with distant organ metastasis treated with chemotherapy alone vs chemotherapy plus total abdominal hysterectomy. read more here.

Keywords: chemotherapy; chemotherapy plus; uterine cancer; cancer distant ... See more keywords
Photo by papaioannou_kostas from unsplash

Efficacy and Safety of Locoregional Radiotherapy With Chemotherapy vs Chemotherapy Alone in De Novo Metastatic Nasopharyngeal Carcinoma: A Multicenter Phase 3 Randomized Clinical Trial.

Sign Up to like & get
recommendations!
Published in 2020 at "JAMA oncology"

DOI: 10.1001/jamaoncol.2020.1808

Abstract: Importance The role of locoregional radiotherapy in patients with de novo metastatic nasopharyngeal carcinoma (mNPC) is unclear. Objective To investigate the efficacy and safety of locoregional radiotherapy in de novo mNPC. Design, Setting, and Participants… read more here.

Keywords: chemotherapy; chemotherapy plus; group; chemotherapy alone ... See more keywords
Photo by nci from unsplash

Comparison of induction chemotherapy plus concurrent chemoradiotherapy and induction chemotherapy plus radiotherapy in locally advanced nasopharyngeal carcinoma.

Sign Up to like & get
recommendations!
Published in 2020 at "Oral oncology"

DOI: 10.1016/j.oraloncology.2020.104925

Abstract: BACKGROUND Induction chemotherapy plus concurrent chemoradiotherapy (IC + CCRT) is a standard treatment regimen for locally advanced nasopharyngeal carcinoma (LA-NPC). However, the increased acute toxicity of this intensified chemotherapy may counteract its efficacy. The results of studies… read more here.

Keywords: chemotherapy; chemotherapy plus; concurrent chemoradiotherapy; plus concurrent ... See more keywords
Photo by nci from unsplash

Cyclophosphamide vs salvage chemotherapy plus G-CSF as chemo-mobilization in Asian patients undergoing autologous hematopoietic stem cell transplant

Sign Up to like & get
recommendations!
Published in 2017 at "Bone Marrow Transplantation"

DOI: 10.1038/bmt.2016.245

Abstract: Cyclophosphamide vs salvage chemotherapy plus G-CSF as chemo-mobilization in Asian patients undergoing autologous hematopoietic stem cell transplant read more here.

Keywords: chemo mobilization; chemotherapy plus; salvage chemotherapy; plus csf ... See more keywords
Photo from wikipedia

Neoadjuvant chemotherapy plus radiation versus chemotherapy plus regional hyperthermia in high-grade soft tissue sarcomas: a retrospective comparison

Sign Up to like & get
recommendations!
Published in 2018 at "International Journal of Hyperthermia"

DOI: 10.1080/02656736.2018.1498137

Abstract: Abstract Purpose: Localized adult high-grade soft tissue sarcomas (STS) usually require multimodality treatment including surgery, radiotherapy, chemotherapy and hyperthermia. If maximal preoperative tumor-shrinkage is envisaged, neoadjuvant chemotherapy + radiation (CRT) is often applied, however at the expense… read more here.

Keywords: chemotherapy; chemotherapy plus; hyperthermia; high grade ... See more keywords
Photo by nci from unsplash

The efficacy and toxicity of induction chemotherapy plus concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma

Sign Up to like & get
recommendations!
Published in 2020 at "Medicine"

DOI: 10.1097/md.0000000000019360

Abstract: Supplemental Digital Content is available in the text read more here.

Keywords: plus concurrent; induction chemotherapy; concurrent chemoradiotherapy; chemotherapy plus ... See more keywords
Photo from wikipedia

Immune Activation in Early-Stage Non–Small Cell Lung Cancer Patients Receiving Neoadjuvant Chemotherapy Plus Ipilimumab

Sign Up to like & get
recommendations!
Published in 2017 at "Clinical Cancer Research"

DOI: 10.1158/1078-0432.ccr-17-2005

Abstract: Purpose: To determine the immunologic effects of neoadjuvant chemotherapy plus ipilimumab in early-stage non–small cell lung cancer (NSCLC) patients. Experimental Design: This is a single-arm chemotherapy plus phased ipilimumab phase II study of 24 treatment-naïve… read more here.

Keywords: chemotherapy plus; ipilimumab; activation; early stage ... See more keywords
Photo from wikipedia

A neutrophil to lymphocyte ratio is predictive of response to neoadjuvant HER2-targeted therapies in the patients with HER2-positive breast cancer.

Sign Up to like & get
recommendations!
Published in 2019 at "Journal of Clinical Oncology"

DOI: 10.1200/jco.2019.37.15_suppl.587

Abstract: 587 Background: The neutrophil to lymphocyte ratio (NLR) has been reported that is associated with response to treatment and prognosis in breast cancer, but its role is unclear in HER2 positive breast cancer. In this… read more here.

Keywords: her2 positive; breast cancer; plus trastuzumab; chemotherapy plus ... See more keywords
Photo from wikipedia

The role of chemotherapy plus immune checkpoint inhibitors in oncogenic driven non-small cell lung cancer: A University of California Lung Cancer Consortium retrospective study.

Sign Up to like & get
recommendations!
Published in 2021 at "Journal of Clinical Oncology"

DOI: 10.1200/jco.2021.39.15_suppl.9059

Abstract: 9059 Background: Immune checkpoint inhibitors (ICIs) have demonstrated limited efficacy in patients (pts) with actionable oncogenic drivers. As a result, pts with the prototypic oncogenic drivers (EGFR and ALK) have purposefully been excluded from many… read more here.

Keywords: chemotherapy; immune checkpoint; lung cancer; chemotherapy plus ... See more keywords
Photo from wikipedia

Targeted neoadjuvant therapy in the HER-2-positive breast cancer patients: a systematic review and meta-analysis

Sign Up to like & get
recommendations!
Published in 2019 at "OncoTargets and therapy"

DOI: 10.2147/ott.s183304

Abstract: Aim To evaluate efficacy and safety of lapatinib or trastuzumab alone or both plus chemotherapy for the treatment of breast cancer patients with positive HER-2 expression. Methods Cochrane Central Register of Controlled Trials, PubMed, MEDLINE,… read more here.

Keywords: chemotherapy; chemotherapy plus; plus lapatinib; breast cancer ... See more keywords